Episode 1: Setting the Record Straight on Obesity and Type 2 Diabetes Medications

Resources for the Community:___________________________________________________________________Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Ro GLP-1 Insurance Checker https://ro.co/weight-loss/glp1-insurance-checker/Ro GLP-1 Supply and Shortage Tracker https://ro.co/weight-loss/supply-tracker/Learn more about Obesity https://www.obesityaction.org/ ______________________________________________________________________In this episode, we discuss the common misconceptions surrounding prescribing GLP1 medications such as Ozempic, Victoza, and Mounjaro, which were initially designed to treat type 2 diabetes and are now being prescribed to treat the disease of obesity. Dr. Michael Albert, an obesity specialist, joins us to set the record straight. ______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide  #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail!Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter,  Producer TikTokInstagram